Consolidated Statement of Changes in Equity (Deficit) - USD ($) $ in Thousands	Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Non-controlling Interest [Member]	Total
Balance at Dec. 31, 2018	$ 2,031	$ 28	$ 32,619	$ (36,993)	$ (161)	$ (2,476)
Balance, shares at Dec. 31, 2018	1,069,941	27,142,979
Issue common stock - registered offerings, net		$ 5	5,374			5,379
Issue common stock - registered offerings, net, shares		5,480,000
Issue common stock - upon partial conversions of Senior Secured Convertible Note		$ 8	8,081			8,089
Issue common stock - upon partial conversions of Senior Secured Convertible Note, shares		7,773,110
Series B Convertible Preferred Stock dividends declared	$ 265			(265)
Series B Convertible Preferred Stock dividends declared, shares	88,268
Issue common stock - Employee Stock Purchase Plan			67			$ 67
Issue common stock - Employee Stock Purchase Plan, shares		82,772				82,772
Stock-based compensation - PAVmed Inc. 2014 Equity Plan			1,397			$ 1,397
Stock-based compensation - majority-owned subsidiary			16		158	174
Loss				(16,457)	(811)	(17,268)
Balance at Dec. 31, 2019	$ 2,296	$ 41	47,554	(53,715)	(814)	(4,638)
Balance, shares at Dec. 31, 2019	1,158,209	40,478,861
Issue common stock - registered offerings, net		$ 11	15,921			15,932
Issue common stock - registered offerings, net, shares		10,647,500
Issue common stock - upon partial conversions of Senior Secured Convertible Note		$ 11	21,692			21,703
Issue common stock - upon partial conversions of Senior Secured Convertible Note, shares		10,929,202
Series B Convertible Preferred Stock dividends declared	$ 284			(284)
Series B Convertible Preferred Stock dividends declared, shares	94,866
Issue common stock - Employee Stock Purchase Plan			357			$ 357
Issue common stock - Employee Stock Purchase Plan, shares		306,555				306,555
Stock-based compensation - PAVmed Inc. 2014 Equity Plan			1,979			$ 1,979
Stock-based compensation - majority-owned subsidiary			13		52	65
Issue common stock - exercise Series S warrants		$ 1	11			12
Issue common stock - exercise Series S warrants, shares		1,199,383
Issue common stock - exercise Series Z warrants, shares		100
Issue common stock - conversion Series B Convertible Preferred Stock	$ (43)		43
Issue common stock - conversion Series B Convertible Preferred Stock, shares	(25,000)	25,000
Vesting of restricted stock awards, shares		233,334				233,334
Issue common stock of majority- owned subsidiary exercise of stock options					5	$ 5
Loss				(34,276)	(1,612)	(35,888)
Balance at Dec. 31, 2020	$ 2,537	$ 64	$ 87,570	$ (88,275)	$ (2,369)	$ (473)
Balance, shares at Dec. 31, 2020	1,228,075	63,819,935